| Events
Column |
|
10/11
10:30 am - 12 noon.
Yale Science
Saturdays: "What's in Your Glass of Water?" Davies
Auditorium, 15 Prospect Street, Yale University, New Haven. more |
|
| 10/16
3:30 pm - 6:30 pm. CURE/Yale BioHaven: Presentation by
Humacyte, Inc. Anylan Center Auditorium, 300 Cedar Street,
New Haven. more |
|
| 10/16
5:00 pm - 7:00 pm. CURE/MIT
Enterprise Forum of CT: Presentation by REM Solutions. New
Haven Lawn Club, 193 Whiney Avenue, New Haven. more |
|
10/18
10:30 am - 12 noon.
Yale Science Saturdays: "Why Do Butterflies Have 'Eyes'
on Their Wings?" Davies Auditorium, 15 Prospect Street,
Yale University, New Haven. more |
|
| 10/22
4:30 pm - 7:30 pm. "From Drug Discovery to Drug
Approval: A Seminar Series on Working with the FDA."
Hosted by CURE and YBPS. Anlyan Center, 300 Cedar Street,
New Haven. more |
|
| 10/23
4:00 pm - 7:00 pm. Connecticut
Venture Group: 2008 Sixth Annual Early Stage and University
Venture Fair, Omni New Haven Hotel at Yale, New Haven. more |
|
10/25
10:30 am - 12 noon.
Yale Science Saturdays: "Molecules that Walk, Shuffle,
and Carry Things Around." Davies Auditorium, 15
Prospect Street, Yale University, New Haven. more |
|
| 10/29
4:30 pm - 7:30 pm. "From Drug Discovery to Drug
Approval: A Seminar Series on Working with the FDA."
Hosted by CURE and YBPS. Anlyan Center, 300 Cedar Street,
New Haven. more |
|
| 11/4
4:30 pm - 7:30 pm. "From Drug Discovery to Drug
Approval: A Seminar Series on Working with the FDA."
Hosted by CURE and YBPS. Anlyan Center, 300 Cedar Street,
New Haven. more |
|
| 11/12
- 11/14 2008
National SBIR Conference. Connecticut Convention Center, 100
Columbus Boulevard, Hartford. more |
|
| 12/2
5:00 pm - 5:45 pm. CURE Annual Meeting. 300 George Street,
New Haven. Watch for details. |
|
| 12/2
5:45 pm - 7:30 pm. CURE Holiday Party. 300 George Street,
New Haven. Watch for details. |
|
|
|
MannKind
Opens New Danbury Insulin Manufacturing Facility
From
the desk of Paul Pescatello, President and CEO of CURE
 With
the problems of Wall Street and Washington omnipresent in
the news, it's a pleasure to report on a very positive
development for the Connecticut economy. MannKind
Pharmaceuticals' decision to build a manufacturing facility
in Danbury for the company's promising new insulin product
is a vote of confidence in the bioscience cluster we've
built in Connecticut.
For
the full story |
|
Alexion's
Soliris™ Honored at Prix Galien USA
Alexion Pharmaceuticals, Inc. of Cheshire has received a Prix Galien USA 2008 Award for Best Biotechnology Product for
Soliris® (eculizumab). The Award recognizes the scientific innovation represented by the complement-inhibition technology of
Soliris®, and the impact the drug is having on the lives of patients with paroxysmal nocturnal hemolglobinuria
(PNH), a rare, debilitating and life-threatening blood disorder.
For
the full story |
|
Deadlines
Approach for Stem Cell Research Applications
The deadline is nearing
to apply for the next round of research grants through the Connecticut Stem Cell Research Grants Program. Deadline for the Letters of Intent is October 31. Deadline for the proposal submissions is December 8.
For
the full story |
|
National
SBIR Conference Scheduled for Hartford
The national SBIR 2008 National Conference will be held this year in Hartford at the Connecticut Convention Center November 12-14. Scheduled highlights of the three-day event include a keynote address by nationally known forensic scientist Dr. Henry Lee.
For
the full story |
|
UConn
Law Clinic Adds Biotech Expert
Geoffrey G. Dellenbaugh, a patent and licensing attorney experienced in the pharmaceutical and biotechnology fields, has joined the UConn Intellectual Property and Entrepreneurship Law Clinic.
The Clinic provides free intellectual property services to small businesses in Connecticut.
For
the full story |
|
CURE
Member News Digest
 454
Life Sciences announces
250th peer review study
Achillion
names Nicholas Simon to Board of Directors
Alexion
draws Prix Galien Honors
Applied
Spine device implanted in local man
Bayer
HealthCare reports news data from BENEFIT study
Boehringer
Ingelheim reports SPIRIVA®
HandiHaler®
results
Bristol-Myers
Squibb comments on ImClone aquisition
Cara
Therapeutics completes opioid Phase 1 trial
CuraGen completes
Phase 2 enrollments
Danbury
Hospital participates in surgery quality
program
GlaxoSmithKline
reports brain effects of nicotine withdrawal
Hartford
Hospital welcomes two leading oncologists
Johnson
& Johnson cites ustekinumab
data
MannKind
completes Phase 3 insulin study
Neurogen focuses
of Phase 2 drug
Pfizer
transfers Exubera patients
PhRMA
applauds IP legislation
Purdue
Pharma reaches agreement with Mallinckrodt Inc.
Quinnipiac
University in ranks of "Best Colleges"
Rib-X
forms clinical advisory board
SBIR-CT to
host national conference
UConn
law clinic adds biotech/pharma expert
Yale
finds angiogenesis RNA
For
the full story |
|
